What are the infectious causes of palpable purpura?

Infectious Causes of Palpable Purpura

The most critical infectious causes of palpable purpura are meningococcemia (Neisseria meningitidis), bacterial endocarditis (particularly Staphylococcus aureus), and rickettsial infections (Rocky Mountain spotted fever and other spotted fever group rickettsioses), with meningococcemia being the most rapidly life-threatening and requiring immediate empiric antibiotic therapy.

Primary Bacterial Pathogens

Meningococcemia (Neisseria meningitidis)

• Most rapidly progressive and lethal infectious cause of palpable purpura 1
• Presents with petechial or purpuric rash that is typically purpuric in nature (89% of cases with rash) 1
• Can progress to purpura fulminans with cutaneous necrosis and gangrene 2
• Critical distinction: Rash progresses more rapidly than in RMSF, often with hypotension, shock, and altered mental state 3
• 37% of meningococcal meningitis cases may NOT have a rash initially 1
• Risk factors for fatal outcome include rapidly progressing rash, hypotension, coagulopathy, and low platelets 1

Bacterial Endocarditis

• Second most important cause to consider in any febrile patient with palpable purpura and cardiac murmur 4, 5, 6
• Most commonly caused by Staphylococcus aureus (including MRSA), particularly in IV drug users 7, 6
• Also caused by viridans streptococci, Streptococcus bovis, HACEK group, and enterococci 4
• Enterococcus faecium can rarely cause purpura fulminans with disseminated intravascular coagulation 8
• Cutaneous vasculitis manifestations can mimic primary vasculitic disorders 5, 6
• Mandatory workup: Blood cultures must be performed in any febrile patient with palpable purpura, especially with cardiac murmur 9

Rickettsial Infections

Rocky Mountain Spotted Fever (RMSF)

• Caused by Rickettsia rickettsii; presents with petechial rash that can progress to palpable purpura 2
• Rash typically appears 3-5 days after fever onset and may involve palms and soles (though only in ~50% of cases late in disease) 3, 2
• Late-stage manifestations include cutaneous necrosis and gangrene that can be confused with meningococcal purpura fulminans 2
• Case-fatality rate: 5-10% overall, but 40-50% if treatment delayed to days 8-9 of illness 2
• Critical timing: Patients treated after day 5 have significantly higher mortality 2

Japanese Spotted Fever and Other Spotted Fever Group Rickettsioses

• Caused by Rickettsia japonica and related species
• Can develop palpable purpura similar to IgA vasculitis after initial petechial rash resolves 10
• Typically presents with fever, rash, eschar, and lymphadenopathy 10

Other Bacterial Causes

• Disseminated gonococcal infection 3
• Group A streptococcal pharyngitis (post-streptococcal purpura) 3
• Leptospirosis 3
• Secondary syphilis 3

Viral Pathogens

Hepatitis Viruses

• Hepatitis B and C are well-established causes of cutaneous vasculitis with palpable purpura 9
• Often associated with mixed cryoglobulinemia 9
• Antiviral treatment can improve control of vasculitis 9

Other Viral Causes

• Cytomegalovirus 9
• Parvovirus B19 3
• Human herpesvirus 6 (roseola) - typically maculopapular rather than purpuric 3
• Enteroviral infections (coxsackievirus, echovirus) 3
• Epstein-Barr virus 3

Diagnostic Approach Algorithm

Immediate Assessment (Within Minutes)

1. Assess hemodynamic stability: Check for hypotension, tachycardia, altered mental status
2. Examine rash characteristics:
   • Distribution (extremities vs. trunk, palms/soles involvement)
   • Progression rate (rapid = meningococcemia)
   • Associated skin findings (eschar suggests rickettsiosis)
3. Cardiac examination: Presence of new or changing murmur suggests endocarditis

Urgent Laboratory Workup

• Blood cultures × 2-3 sets before antibiotics (mandatory) 4, 9
• Complete blood count with differential (look for thrombocytopenia, leukopenia) 3, 2
• Comprehensive metabolic panel (hyponatremia, elevated transaminases) 3, 2
• Coagulation studies (DIC screen if purpura fulminans suspected) 8
• Lactate level (>4 mmol/L indicates cryptic shock) 1

Risk Stratification for Empiric Therapy

Immediate empiric antibiotics required if ANY of:

• Rapidly progressive purpuric rash
• Hypotension or shock
• Altered mental status
• Fever with cardiac murmur
• Lactate >4 mmol/L
• Thrombocytopenia with coagulopathy

Empiric regimen for suspected meningococcemia: Ceftriaxone 2g IV immediately 1

Empiric regimen for suspected endocarditis: Vancomycin + ceftriaxone (or gentamicin) 7, 4

Empiric regimen for suspected RMSF: Doxycycline 100mg PO/IV BID (do NOT wait for confirmation) 2

Critical Pitfalls to Avoid

1. Delaying antibiotics for diagnostic workup in unstable patients - mortality increases dramatically with each hour of delay 2, 1
2. Assuming absence of fever or rash rules out infection - 37% of meningococcal cases lack rash initially 1
3. Missing endocarditis in IV drug users - always obtain blood cultures before antibiotics 6
4. Treating presumed vasculitis with immunosuppression before excluding infection - can be fatal 5
5. Waiting for palms/soles involvement in RMSF - this occurs late and only in 50% of cases 3, 2
6. Assuming normal blood pressure excludes shock - young patients maintain BP until late (cryptic shock) 1

Pathogenic Mechanisms

The infectious origin is demonstrated in less than 30% of cases of leukocytoclastic vasculitis, making empiric treatment decisions critical 9. Mechanisms include:

• Immune complex formation and deposition
• Direct vessel damage by infectious agents
• Mixed cryoglobulinemia (especially hepatitis B/C)
• Acquired protein C deficiency (purpura fulminans) 8